Minimally invasive surgery for hepatocellular carcinoma
- PMID: 36914596
- DOI: 10.1097/JCMA.0000000000000915
Minimally invasive surgery for hepatocellular carcinoma
Conflict of interest statement
Conflicts of interest: Dr. Peng-Hui Wang, an editorial board member at Journal of the Chinese Medical Association , had no role in the peer review process of or decision to publish this article. The other authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
Comment on
-
Robot-assisted versus open hepatectomy for liver tumors: Systematic review and meta-analysis.J Chin Med Assoc. 2023 Mar 1;86(3):282-288. doi: 10.1097/JCMA.0000000000000870. Epub 2023 Jan 9. J Chin Med Assoc. 2023. PMID: 36622784 Free PMC article.
References
-
- Lee WL, Wang PH, Yang ST, Liu CH, Chang WH, Lee FK. To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases. J Chin Med Assoc. 2022;85:1109–19.
-
- Wang SY, Huang YH, Liang YJ, Wu JC. Gene coexpression network analysis identifies hubs in hepatitis B virus-associated hepatocellular carcinoma. J Chin Med Assoc. 2022;85:972–80.
-
- Chang TE, Su CW, Huang YS, Huang YH, Hou MC, Wu JC. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: a meta-analysis. J Chin Med Assoc. 2022;85:30–41.
-
- Chen YJ, Su CW, Wei CY, Chau GY, Chen PH, Chao Y, et al. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resection. J Chin Med Assoc. 2022;85:679–86.
-
- Wu HL, Liu HY, Liu WC, Hou MC, Tai YH. A predictive model incorporating inflammation markers for high-grade surgical complications following liver resection for hepatocellular carcinoma. J Chin Med Assoc. 2022;85:845–52.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
